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Results
Conclusions
• The results from this model predict a rapid and sustained decrease of varicella in Hungary, achieving near-elimination status within ten years.
• Notably, rapid disease reduction is seen even in age groups not vaccinated.
• The results indicate that the herd immunity threshold in Hungary is probably towards the lower end of previous results estimated in Europe 23 to range between 69.8%(Italy) and 94.1%(Netherlands), likely due to a combination of factors including a low birth rate • Further work to explore the cost-effectiveness of a national varicella vaccination program is warranted, given the demonstration shown of public health impact
• A rapid reduction of the burden of varicella will occur with both cases and deaths reduced by 99% within 10 years, assuming a 90% coverage rate with a single dose of vaccine administered at 15 months • Public health benefits extend beyond vaccinees, with a 98.6% reduction in disease in infants too young to be vaccinated 
Limitations
• The absence of direct serological data from Hungary requires reliance on assumptions from pan-European data to calibrate the model • The age-specific case-fatality rates were based on data from other countries published quite some time ago • The impact (if any) on herpes zoster is not captured in the results
Methods
• Adaptation of deterministic, compartment-based, age-structured dynamic transmission models 15 x Q ≈
Figure 2. Model calibration
The relative age distribution of cases from EUVAC.net 21, 22 countries that reported age distribution of cases is shown as bars from three different time periods; it has been rescaled by the factor Q≈2. The solid line shows the calibrated model fit. 
